Annual Working Capital
-$4.28 M
-$1.72 M-67.26%
December 31, 2023
Summary
- As of February 8, 2025, ABVC annual working capital is -$4.28 million, with the most recent change of -$1.72 million (-67.26%) on December 31, 2023.
- During the last 3 years, ABVC annual working capital has fallen by -$5.60 million (-421.83%).
- ABVC annual working capital is now -207.93% below its all-time high of $3.96 million, reached on December 31, 2021.
Performance
ABVC Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
-$4.17 M
+$192.10 K+4.41%
September 30, 2024
Summary
- As of February 8, 2025, ABVC quarterly working capital is -$4.17 million, with the most recent change of +$192.10 thousand (+4.41%) on September 30, 2024.
- Over the past year, ABVC quarterly working capital has dropped by -$1.30 million (-45.23%).
- ABVC quarterly working capital is now -167.83% below its all-time high of $6.14 million, reached on June 30, 2022.
Performance
ABVC Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ABVC Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -67.3% | -45.2% |
| 3 y3 years | -421.8% | -213.5% |
| 5 y5 years | +21.9% | -213.5% |
ABVC Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -207.9% | at low | -167.8% | +13.9% |
| 5 y | 5-year | -207.9% | +28.0% | -167.8% | +39.2% |
| alltime | all time | -207.9% | +33.0% | -167.8% | +61.8% |
ABVC BioPharma Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$4.17 M(-4.4%) |
| Jun 2024 | - | -$4.36 M(-9.9%) |
| Mar 2024 | - | -$4.84 M(+13.2%) |
| Dec 2023 | -$4.28 M(+67.3%) | -$4.28 M(+49.0%) |
| Sep 2023 | - | -$2.87 M(-21.3%) |
| Jun 2023 | - | -$3.64 M(+128.5%) |
| Mar 2023 | - | -$1.59 M(-37.6%) |
| Dec 2022 | -$2.56 M(-164.5%) | -$2.56 M(+157.9%) |
| Sep 2022 | - | -$991.20 K(-116.1%) |
| Jun 2022 | - | $6.14 M(+42.1%) |
| Mar 2022 | - | $4.32 M(+9.2%) |
| Dec 2021 | $3.96 M(+198.2%) | $3.96 M(+7.9%) |
| Sep 2021 | - | $3.67 M(-590.7%) |
| Jun 2021 | - | -$748.40 K(-238.8%) |
| Mar 2021 | - | $539.20 K(-59.4%) |
| Dec 2020 | $1.33 M(-122.4%) | $1.33 M(-127.3%) |
| Sep 2020 | - | -$4.87 M(-18.5%) |
| Jun 2020 | - | -$5.97 M(-12.9%) |
| Mar 2020 | - | -$6.85 M(+15.4%) |
| Dec 2019 | -$5.94 M(+8.5%) | -$5.94 M(+42.3%) |
| Sep 2019 | - | -$4.17 M(-53.0%) |
| Jun 2019 | - | -$8.87 M(-18.7%) |
| Mar 2019 | - | -$10.91 M(+99.3%) |
| Dec 2018 | -$5.47 M(+211.5%) | -$5.47 M(+190.4%) |
| Sep 2018 | - | -$1.88 M(+11.9%) |
| Jun 2018 | - | -$1.68 M(-12.9%) |
| Mar 2018 | - | -$1.93 M(+10.0%) |
| Dec 2017 | -$1.76 M(+26.1%) | -$1.76 M(+26.1%) |
| Sep 2017 | - | -$1.39 M(+32.9%) |
| Sep 2017 | -$1.39 M(-78.2%) | - |
| Jun 2017 | - | -$1.05 M(+13.6%) |
| Mar 2017 | - | -$922.80 K(-85.8%) |
| Dec 2016 | - | -$6.52 M(+2.1%) |
| Sep 2016 | -$6.38 M(-1114.0%) | -$6.38 M(-519.0%) |
| Jun 2016 | - | $1.52 M(+75.7%) |
| Mar 2016 | - | $866.90 K(>+9900.0%) |
| Dec 2015 | - | $300.00(-100.0%) |
| Sep 2015 | $629.50 K | $629.50 K(-1919.4%) |
| Jun 2015 | - | -$34.60 K(-3.6%) |
| Mar 2015 | - | -$35.90 K(+2.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | - | -$35.10 K(+5.7%) |
| Sep 2014 | -$33.20 K(-1847.4%) | -$33.20 K(-1847.4%) |
| Sep 2013 | $1900.00(-100.1%) | $1900.00(-100.1%) |
| Mar 2013 | - | -$2.08 M(+1.9%) |
| Dec 2012 | - | -$2.04 M(+7.5%) |
| Sep 2012 | -$1.90 M(+9.6%) | -$1.90 M(+10.9%) |
| Jun 2012 | - | -$1.71 M(+3.6%) |
| Mar 2012 | - | -$1.65 M(+1.7%) |
| Dec 2011 | - | -$1.63 M(-6.1%) |
| Sep 2011 | -$1.73 M(-46.8%) | -$1.73 M(+5.6%) |
| Jun 2011 | - | -$1.64 M(-3.4%) |
| Mar 2011 | - | -$1.70 M(-50.7%) |
| Dec 2010 | - | -$3.44 M(+5.6%) |
| Sep 2010 | -$3.25 M(+28.8%) | -$3.25 M(+12.2%) |
| Jun 2010 | - | -$2.90 M(+2.3%) |
| Mar 2010 | - | -$2.84 M(+14.1%) |
| Dec 2009 | - | -$2.48 M(-1.7%) |
| Sep 2009 | -$2.53 M(+45.1%) | -$2.53 M(+1.4%) |
| Jun 2009 | - | -$2.49 M(-2.0%) |
| Mar 2009 | - | -$2.54 M(+3.7%) |
| Dec 2008 | - | -$2.45 M(+40.7%) |
| Sep 2008 | -$1.74 M(+5069.7%) | -$1.74 M(-37.8%) |
| Jun 2008 | - | -$2.80 M(+90.4%) |
| Mar 2008 | - | -$1.47 M(+45.4%) |
| Dec 2007 | - | -$1.01 M(-9056.6%) |
| Sep 2007 | -$33.70 K(-195.5%) | - |
| Jun 2007 | - | $11.30 K(-52.7%) |
| Mar 2007 | - | $23.90 K(-32.3%) |
| Dec 2006 | $35.30 K(-41.8%) | $35.30 K(-20.7%) |
| Sep 2006 | - | $44.50 K(-2.2%) |
| Jun 2006 | - | $45.50 K(-13.7%) |
| Mar 2006 | - | $52.70 K(-13.2%) |
| Dec 2005 | $60.70 K(-30.5%) | $60.70 K(-11.3%) |
| Sep 2005 | - | $68.40 K(-8.4%) |
| Jun 2005 | - | $74.70 K(-4.8%) |
| Mar 2005 | - | $78.50 K(-10.1%) |
| Dec 2004 | $87.30 K(+2.9%) | $87.30 K(-6.9%) |
| Sep 2004 | - | $93.80 K(+28.8%) |
| Jun 2004 | - | $72.80 K(-9.0%) |
| Mar 2004 | - | $80.00 K |
| Dec 2003 | $84.80 K | - |
FAQ
- What is ABVC BioPharma annual working capital?
- What is the all time high annual working capital for ABVC BioPharma?
- What is ABVC BioPharma annual working capital year-on-year change?
- What is ABVC BioPharma quarterly working capital?
- What is the all time high quarterly working capital for ABVC BioPharma?
- What is ABVC BioPharma quarterly working capital year-on-year change?
What is ABVC BioPharma annual working capital?
The current annual working capital of ABVC is -$4.28 M
What is the all time high annual working capital for ABVC BioPharma?
ABVC BioPharma all-time high annual working capital is $3.96 M
What is ABVC BioPharma annual working capital year-on-year change?
Over the past year, ABVC annual working capital has changed by -$1.72 M (-67.26%)
What is ABVC BioPharma quarterly working capital?
The current quarterly working capital of ABVC is -$4.17 M
What is the all time high quarterly working capital for ABVC BioPharma?
ABVC BioPharma all-time high quarterly working capital is $6.14 M
What is ABVC BioPharma quarterly working capital year-on-year change?
Over the past year, ABVC quarterly working capital has changed by -$1.30 M (-45.23%)